Dear Editor,
A 72-year-old woman was admitted to the hospital with acute perioral paresthesia and dysarthria that she never experienced before. She reported mild fever and headache for the previous 3 days. She had low serum total (4.75 mg/dl) and ionized (2.09 mg/dl) calcium, hyperphosphatemia (5.2 mg/dl), slightly increased serum creatinine (1.54 mg/dl), and respiratory alkalosis (pH 7.5, PCO2 29 mmHg, PO2 74 mmHg). Total proteins and albumin were normal (69.2 g/L and 40 g/L, respectively). She had lymphocytopenia, increased lactate dehydrogenase (515 IU/L), and C-reactive protein levels (28.2 mg/L). She reported total thyroidectomy 19 years ago on l-thyroxine 100 μg/day, arterial hypertension on angiotensin-converting enzyme inhibitors, and hydrochlorothiazide and mild renal insufficiency from several years. The chest X-ray did not show signs of pneumonia. Nasopharyngeal swab for Covid-19 was performed due to contact with a suspect infected subject.
Intravenous infusion of calcium gluconate was initiated with immediate beneficial effects on hypocalcemic symptoms and progressive amelioration of calcium so she could be switched to oral treatment. The patient resulted positive to Covid-19 test. PTH was 10 pg/ml (n.r. 15–65) and 25-OH vitamin D 8 ng/ml, with normal FT4 and TSH. The patient underwent resolution of fever and headache and was discharged after 9 days with normal calcemia (9.1 mg/dl) on oral calcitriol 0.25 μg/day and calcium carbonate 1000 mg/day [1].
This is the first case of Covid-19 infection as the possible precipitating cause of subclinical post-surgical hypoparathyroidism presenting with severe hypocalcemia. Hypocalcemia was already shown to be common in patients with SARS (60% of patients at hospital admission), although generally mild [2], and in patients with Ebola virus disease (62%) [3]. So far, hypocalcemia was not reported among the main laboratory features of Covid-19 infection [4]. In this case, besides the previous thyroidectomy, possible contributing factors could have been renal insufficiency, hydrochlorothiazide treatment (although both long-standing), and respiratory alkalosis which is quite commonly reported also in seriously ill Covid-19 patients [4].
This case suggests that hypocalcemia may occur also in Covid-19 infection. Therefore, all patients with postsurgical hypoparathyroidism should continue their treatment to avoid severe acute hypocalcemia which can be life-threatening [1] and since vitamin D deficiency, worsened by home confinement, may predispose to systemic infections [5]. Moreover, mild hypoparathyroid patients not requiring chronic treatment should undergo careful surveillance in areas characterized by the outbreak of Covid infection. Finally, since hypocalcemia may have a negative impact on cardiac outcomes [4], we suggest calcium evaluation and monitoring in all hospitalized patients with Covid-19 infection.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Tecilazich F, Formenti AM, Frara S, Giubbini R, Giustina A. Treatment of hypoparathyroidism. Best Pract. Res Clin. Endocrinol. Metab. 2018;32(6):955–964. doi: 10.1016/j.beem.2018.12.002. [DOI] [PubMed] [Google Scholar]
- 2.Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL, Mazzulli T, Avendano M, Derkach P, Ephtimios IE, Kitai I, Mederski BD, Shadowitz SB, Gold WL, Hawryluck LA, Rea E, Chenkin JS, Cescon DW, Poutanen SM, Detsky AS. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289(21):2801–2809. doi: 10.1001/jama.289.21.JOC30885. [DOI] [PubMed] [Google Scholar]
- 3.Uyeki TM, Mehta AK, Davey RT, Jr., Liddell AM, Wolf T, Vetter P, Schmiedel S, Grünewald T, Jacobs M, Arribas JR, Evans L, Hewlett AL, Brantsaeter AB, Ippolito G, Rapp C, Hoepelman AI, Gutman J, Working Group of the U.S.–European Clinical Network on Clinical Management of Ebola Virus Disease Patients in the U.S. and Europe Clinical management of Ebola virus disease in the United States and Europe. N. Engl. J. Med. 2016;374(7):636–646. doi: 10.1056/NEJMoa1504874. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020 doi: 10.1001/jama.2020.1585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B, Lips P, Munns CF, Lazaretti-Castro M, Giustina A, Bilezikian J, et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr. Rev. 2019;40(4):1109–1151. doi: 10.1210/er.2018-00126. [DOI] [PMC free article] [PubMed] [Google Scholar]